2008
DOI: 10.1016/j.jalz.2008.05.2427
|View full text |Cite
|
Sign up to set email alerts
|

P4‐356: Decreased activation along the dorsal visual pathway after three month treatment with galantamine in mild Alzheimer's disease: An fMRI study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Thus we believe that the slow RT and greater DMN deactivation we see are unlikely to be due to dopaminergic medication. Cholinergic drugs have been reported to improve attentional function (Bentley et al, ; Broks et al, ; McKeith et al, ), largely by modulating frontoparietal networks (Bentley et al, ; Bokde et al, ; Risacher et al, ). Most of the LBD patients were taking cholinesterase inhibitor medication, which has been shown to result in faster RT in Parkinson's disease (Rowan et al, 2007), so may have reduced response latencies in subjects, although we did not see any differences in those patients taking such medication compared to those not on these agents.…”
Section: Discussionmentioning
confidence: 99%
“…Thus we believe that the slow RT and greater DMN deactivation we see are unlikely to be due to dopaminergic medication. Cholinergic drugs have been reported to improve attentional function (Bentley et al, ; Broks et al, ; McKeith et al, ), largely by modulating frontoparietal networks (Bentley et al, ; Bokde et al, ; Risacher et al, ). Most of the LBD patients were taking cholinesterase inhibitor medication, which has been shown to result in faster RT in Parkinson's disease (Rowan et al, 2007), so may have reduced response latencies in subjects, although we did not see any differences in those patients taking such medication compared to those not on these agents.…”
Section: Discussionmentioning
confidence: 99%
“…Another limitation was the effect of concurrent psychotropic medication. Cholinergic drugs are reported to improve attentional function in controls and dementia [Bentley et al, ; Broks et al, ; McKeith et al, ], mostly by modulating frontoparietal networks [Bentley et al, ; Bokde et al, ; Risacher et al, ]. All but five patients were on cholinesterase inhibitors, thus an effect of these cannot be ruled out.…”
Section: Discussionmentioning
confidence: 99%